Detrusor smooth muscle (DSM) cells present within the urinary bladder wall ultimately facilitate urine storage and voiding. Preparation of the viable, fresh, and isolated DSM cells presents an important technical challenge whose achievement provides optimal cells for subsequent functional and molecular studies. The method developed and elaborated herein, successfully used by our group for over a decade, describes dissection of human urinary bladder specimens obtained from open bladder surgeries followed by an enzymatic two-step treatment of DSM pieces and mechanical trituration to obtain freshly isolated DSM cells. The initial step involves dissection to separate the DSM layer (also known as muscularis propria) from mucosa (urothelium, lamina propria, and muscularis mucosa) and the adjacent connective, vascular, and adipose tissues present. The DSM is then cut into pieces (2-3 mm x 4-6 mm) in nominal Ca 2+ -containing dissection/digestion solution (DS). DSM pieces are next transferred to and sequentially treated separately with DS containing papain and collagenase at ~37 °C for 30-45 min per step. Following washes with DS containing enzyme-free bovine serum and trituration with a fire-polished pipette, the pieces release single DSM cells. Freshly isolated DSM cells are ideally suited for patch-clamp electrophysiological and pharmacological characterizations of ion channels. Specifically, we show that the TRPM4 channel blocker 9-phenanthrol reduces voltage-step evoked cation currents recorded with the amphotericin-B perforated patch-clamp approach. DSM cells can also be studied by other techniques such as single cell RT-PCR, microarray analysis, immunocytochemistry, in situ proximity ligation assay, and Ca 2+ imaging. The main advantage of utilizing single DSM cells is that the observations made relate directly to single cell characteristics revealed. Studies of freshly isolated human DSM cells have provided important insights characterizing the properties of various ion channels including cation-permeable in the urinary bladder and will continue as a gold standard in elucidating DSM cellular properties and regulatory mechanisms.
Introduction
Detrusor smooth muscle (DSM) cells constitute the most abundant cell type in the urinary bladder and ultimately control urine storage and voiding through relaxation and contraction, respectively. DSM cells form smooth muscle bundles that intertwine with adjacent connective tissue, nerve processes, interstitial cells, and other cell types Single DSM cells provide a source for multiple molecular biology and physiological experiments. So far, protein and mRNA expressions studied with immunocytochemistry, or RT-PCR/qRT-PCR determinations revealed high levels of detection for various ion channels including the large conductance voltage-and Ca 2+ -activated (BK), small conductance Ca 2+ -activated K + type 3 (SK3), voltage-gated K + (K v ), L-type voltage-gated Ca 2+ (Ca v ), and transient receptor potential melastatin type 4 (TRPM4) channels, as well as a Na/Ca 2+ exchanger 14, 15, 16, 17, 18, 19, 20, 21, 22 . They are all thought to control DSM excitability, intracellular Ca 2+ levels and contractility. Patch-clamp electrophysiological approaches, performed directly on guinea pig, mouse, rat, or human DSM cells, provided direct demonstration of biophysical and pharmacological properties of L-type Ca v , K v (K v 2.x. K v 7), SK, BK, and TRPM4 channels 17, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31 . The approaches included a conventional whole-cell voltage-clamp, a perforated voltage-clamp, and single-channel recordings (cell attached, inside-out and outside-out configurations). Additionally, membrane potential recording of DSM using a current-clamp provided evidence that target-engaging pharmacological agents alter the cell excitability. For example, the TRPM4 inhibitor 9-phenanthrol induced hyperpolarization in DSM cells obtained from humans, guinea pig, and rat urinary bladders 19, 20, 22, 31 . Among the various electrophysiological methods, the amphotericin-B (and nystatin, gramicidin, and β-escin) perforated patchclamp recordings provide a key advantage by preserving intrinsic intracellular signaling molecules and pathways. Only low molecular weight cations and to a lesser extent, Cl --but not proteins or signaling molecules including Ca 2+ -are permeable through the plasma membrane pores formed by amphotericin-B or nystatin 32 . The successful outcome of perforated patch-clamp experiments depends on several general variables unique to this technique. Here, we describe the details of the procedure utilizing amphotericin-B that our group has used successfully over the years 15, 22, 33, 34, 35, 36, 37, 38, 39 .
Arguably, non-selective cation channels remain one of the least understood channel types in DSM cells. The first report of a non-selective cation-like channel dates back to 1993. The paper by Wellner and Isenberg 11 , and inhibition of channel activity by Gd 3+ , a general inhibitor of non-selective cation channels. Almost a decade later, Thorneloe and Nelson 40 described Na + permeable cation currents in mouse DSM cells, inhibited by Gd 3+ , using whole-cell recordings. Since molecular identities of non-selective cation channels and their biophysical characterizations remain to be determined, future investigations in this research area are warranted. The protocol described herein for the recording of non-selective cation channel currents -using extracellular and pipette intracellular solutions containing Cs + , TEA + , and nifedipine ( Table 2 ) that physiologically and pharmacologically mitigate K v and Ca v currents -has been and will continue to be useful in electrophysiological investigations of non-selective cation channels. We have utilized this specific protocol to determine the extent of inhibition of whole-cell cation currents by the TRPM4 channel blocker 9-phenanthrol in guinea pig, rat and human DSM cells 19, 20, 22 . Taken together, the method described here for obtaining freshly isolated single DSM cells from human urinary bladder provides viable cells highly suitable for electrophysiological investigations using various configurations of the patch-clamp technique, Ca 2+ -imaging, immunocytochemistry, in situ proximal litigation assay, and single cell RT-PCR/qRT-PCR as well as advanced molecular biology techniques including microarray analysis, RNA-seq, and CHIP-seq. The use of the amphotericin-B perforated patch-clamp method preserves the native cell environment unlike other configurations. When carried out using the specific conditions outlined here, designed to negate contributions of K + and Ca 2+ currents in DSM cells, voltage-step induced currents display the properties of non-selective cation currents suitable for biophysical and pharmacological characterizations.
Protocol
All methods described here have been approved by Institutional Review Board Committees of the University of Tennessee Health Science Center (Memphis, TN, IRB# 17-05714-XP), and the Medical University of South Carolina (Charleston, SC, IRB# 00045232). The approved procedures allow whole thickness urinary bladder specimens (>1 cm by >1 cm) -containing all layers including mucosa, detrusor smooth muscle, and serosa as well are attached blood vessels and adipose tissue) -to be collected from patients-donors undergoing surgical partial extraction of bladder. Patient-donors are adult (age range studied until now: 25 to 87 years old), either male or female, with or without symptoms of overactive bladder (as classified by American Urological Association I-PSS score 41 ). Surgical procedures involve a variety of medical conditions including radical cystectomy for urothelial carcinoma, and adenocarcinoma. In such cases, the collected urinary bladder specimen is remote from the site of tumor. NOTE: To optimally control the temperature for enzymatic treatment, tubes with tissue pieces and enzyme solutions are placed in either a glass tissue chamber filled with water connected to a circulating heated water bath ( Figure 1D ) or a high-precision temperature-controlled shaking water bath (Figure 1E ). DS-P from the tube, briefly wash DSM pieces with ice cold DS, discard cold DS from the tube leaving DSM pieces sitting at the  bottom of the tube.  3. Add 1 to 2 mL of DS-containing collagenase type II (DS-C, Table 2 ) to the tube with DSM pieces, gently mix; and incubate for 25-40 min at 37 °C gently shaking the tube occasionally (every 10-15 min). 4. Discard DS-C and wash enzyme-treated DSM pieces 5-10 times with ice-cold DS. 5. Following the last wash, leave DS solution inside the tube; gently triturate with a fire-polished Pasteur pipette several times to release single DSM cells. 6. Place a few drops of DS solution containing dispersed DSM cells onto a glass-bottom chamber or a coverslip and visually inspect for the quality under a microscope (using a 20x or 40x objective) after at least 5 min following the application to allow the cells to adhere to the bottom. 7. Immediately use freshly isolated DSM cells for electrophysiological experiments or store the cells in a tube containing DS at ~4 °C either on ice or in a refrigerator until use (typically for up to 8 h of preparation). NOTE: Within the same preparation the quality of cells varies from highly viable to over-digested, dead DSM cells (Figure 2) . When the sequential papain-collagenase method yields a very high number of unviable cells, the preparation is discarded, and a new digestion of DSM pieces is carried out but with reduced incubation intervals. If the procedure results in too few DSM cells then for the subsequent digestion of DSM pieces, the incubation intervals are increased. Positive immunoreactivity to α-smooth muscle actin confirms the identity of DSM cells (Figure 3 ). Table 2 ) to obtain a final concentration of 200-500 µg/mL. This step requires extensive sonication and vortexing at a high-speed setting (8-10/10) for ~30 to 60 min per step to ensure optimal mixing and prevention of amphotericin-B precipitate formation in the pipette solution. NOTE: Amphotericin-B will precipitate over-time and is light-sensitive. The working pipette solution containing Amphotericin-B is checked for solubility, hand-mixed prior to pipette filling, and kept in the dark. 5. Pull multiple patch electrodes, fire-polish electrode tips, and (if needed) coat the tips with dental wax. 6. Fill the tip of a patch electrode with the pipette solution (solution P, Table 2 ) without amphotericin-B by briefly dipping the electrode in the solution. 7. Backfill the electrode with the same pipette solution containing amphotericin-B. 8. Mount the electrode onto a holder connected to a patch-clamp amplifier headstage. 9. Using a micromanipulator, place the electrode just below the surface of the extracellular solution so that the tip of the electrode is just submerged. 10. In the voltage-clamp mode, set the holding potential to 0 mV and adjust the current to 0 pA with the pipette offset dial on the commercial amplifier (Table of Materials). 11. Determine the electrode resistance using the Membrane Test window/function of the commercial acquisition software (Table of Materials). To activate click Tools>Membrane Test>Play or a shortcut icon in the software. The determined electrode resistance should be in the range of 2 to 5 MΩ. NOTE: Membrane Test function provided in the commercial acquisition software or Seal Test option on the amplifier can be used to monitor electrode resistance by applying voltage steps repetitively. 12. Continue monitoring electrode resistance while advancing the electrode toward a chosen DSM cell with a micromanipulator (Figure 4A) . NOTE: To be considered a viable DSM cell, the cell must show spindle-shaped elongated morphology, a well-defined halo around the cell, crisp edges, and semi-contractile (serpentine) appearance.
Remove

Recording voltage-step induced cation currents from DSM cells using amphotericin-B perforated whole-cell voltage patch-clamp technique
When touching the cell surface with the electrode -indicated by a rapid increase in the electrode resistance measured with the Membrane
Test function -form a giga-seal by applying gentle rapid negative pressure to the electrode holder via tubing. This results in negative pressure created at the tip of the electrode that pulls cell membrane into electrode aiding in the formation of a giga-seal or a very tight contact between the electrode and plasma membrane ( Figure 4B ). 14. Once the giga-seal forms, compensate pipette capacitance by adjusting fast and slow dials on the commercial amplifier and monitor giga-seal stability (leak current) using the Membrane Test function. 15. Allow time, typically 30-60 min, for amphotericin-B to diffuse down the pipette and be inserted into the plasma membrane forming pores primarily selective to monovalent cations. During this step, continue monitoring the giga-seal with the Membrane Test function. As cell perforation increases so does the amplitude of the capacitance transients (compare Figure 4B versus Figure 4C displaying no and effective cell perforation, respectively) measured with the Membrane Test function. 16 . When the patch perforation is optimal (judged by stable series resistance typically below 50 MΩ), cancel out the capacitance transients by adjusting the dials for cell capacitance and series resistance on the amplifier. Series resistance compensation can also be performed at this time ( Figure 4D ). 17. Once stable voltage-step induced cation currents evoked by the specified protocol are observed, apply a compound or physiological condition to test by superfusion and record the responses for the control-, test-condition, and washout (if possible) with the commercial acquisition software. 1. Record currents with a routine voltage-step protocol that involves holding DSM cells at -64 or -74 mV and stepping the voltage in 10 mV increments for 400 or 500 ms from -94 to +96 or +106 mV and returning to the holding potential. NOTE: The membrane potential values are adjusted for a liquid junction potential of 14 mV (using P and E solutions, Table 2 ). The liquid junction potential is obtained in the commercial acquisition software (Table of Materials) by clicking (Tools>Junction Potentials) and entering the concentrations of solution ion components. A ramp protocol can also be used to obtain current recordings. 2. Run the voltage-protocol in continuous ~1 min interval during an experiment recording currents for pre-addition control, test condition, and washout.
Data analysis and visualization
1. Open recorded files in the commercial data analysis software ( 3. For each cell, normalize the responses for all three conditions to the value of the maximum voltage step for the pre-addition control (according to the formula: Response/Response Control-Max ) and graph the responses as current (or current density) values versus voltage relationships (Figure 6 ). 1. In a worksheet processor, determine the average responses as either currents (pA) or current densities (pA/pF) for control, test condition (in this example, 9-phenanthrol) , and washout at each voltage step. 2. Divide values for each voltage of each condition (control, 9-phenanthrol, and washout) by the maximum control response obtained at the highest voltage (+96 mV in Figure 6 ) for the pre-addition control following the formula: Normalized response for condition(x) = Response(x)/ Response Control-Max for (x) .
4. For summary analysis, arrange the data in a format that can be easily copied to a graphical program (e.g. GraphPad Prism) for visualization.
Representative Results
Enzymatic dissociation of DSM pieces provides healthy freshly isolated DSM cells routinely used in functional and molecular studies such as: patch-clamp electrophysiology and immunocytochemistry. Figure 1 summarizes the dissection steps and visualizes the setups employed for temperature control of enzymatic treatment steps. Figure 2 illustrates bright-field images of DSM cells obtained from three human urinary bladder specimens each from a different patient-donor. Healthy single DSM cells are characterized by spindle-shaped morphology, crisp welldefined edges, a well-defined halo around the cell, and semi-contractile (serpentine-like) appearance when viewed under the microscope (see DSM cells demarked by white arrows in Figure 2 ). They also respond to contraction stimulating agents such as the muscarinic agonist carbachol or high K + (60 mM) applications. DSM cells show positive immunoreactivity for α-smooth muscle actin confirming their identity (Figure 3) .
DSM cells are ideally suited for patch-clamp electrophysiological investigations of ion channel properties. Here, we describe the amphotericin-B perforated patch-clamp recording method using pipette and extracellular solutions ( Table 2) to optimally record voltage-step induced cation channels. Under the specific conditions employed, blockade of K v and L-type Ca 2+ currents with Cs + /TEA + and nifedipine, respectively, ensured the elimination of contribution of these ionic components to the whole-cell voltage-evoked currents. Figure 4 and Figure 5 show, respectively, the experimental steps of the amphotericin-B perforated patch-clamp method and representative whole-cell currents measured either with a voltage-step induced or a ramp protocol in three different human DSM cells, each from a different patient donor. Note that the recordings display a certain degree of variability in terms of current amplitudes and outward rectification. Additional experiments revealed that 9-phenanthrol, a Guinea pig DSM pieces rinsed with Ca 2+ -free medium (in mM: 100 NaCl, 10 KCl, 1.2 KH 2 PO 4 , 5 MgCl 2 , 20 glucose, 50 taurine, measured pCa=6 (or 1 mM) and then cut into pieces and treated typically 90-120 min (4 periods of 30 min) with enzyme medium (in mM: 130 KOH, 20 taurine, 5 pyruvate, 5 creatine, 10 mM HEPES, adjusted with methansulfonic acid to pH 7.4, 1 mg/ml collagenase, 0.2 mg/ml pronase E, 1 mg/ml fatty acid free albumin, pCa=4.2 (63 mM) or 3.7 (200 mM). Single DSM cells were stored in Kraft-Bruhe (KB)-medium (in mM: 85 KCl, 30 K 2 PO 4 , 5 MgSO 4 , 5 Na 2 ATP, 5 K-pyruvate, 5 creatine, 20 taurine, 5 beta-OH-butyrate, 1 mg/ml fatty acid free albumin, adjusted with KOH to pH 7.2). Alternative method: DSM pieces rinsed for 10 min in a Ca 2+ -free medium (in mM): 140 NaCl, 5 KCl, 1.2 MgCl 2 , 10 glucose, 20 taurine, 5 HEPES, adjusted with NaOH to pH 7.4). Then DSM pieces, incubated in the same Ca 2+ -free medium complemented with 5 mg% collagenase, 2 mg% pronase and 100 μM CaCl 2 for 2x20 min stirring.
Klockner & Isenberg (1985) 13, 34 Klockner & Isenberg (1986) 35 Schneider et al. (1991) 10 Bonev & Isenberg (1992) 9 Weidelt & Isenberg (2000) 36 Moore et al. 14 Guinea pig, Landrace pig, and human DSM pieces pre-incubated for 5 min in Ca 2+ -free Krebs solution then cut into pieces and enzymatically digested in Ca 2+ -free Krebs solution containing 0.5-2 mg/ml collagenase type I and 0.1-0.5 mg/ml pronase at 36°C for 20-30 min constantly stirred. In some cases, digested pieces were further agitated by a blunt tipped pipette or by spinning until yielding cells. Isolated cells were stored in modified Krebs solution (described in Klockner & Isenberg 13 ) and were normally used within 3 h. Guinea pig, mouse, rat, and human Protocol utilizes a two-step enzymatic dissociation treatment following sharp dissection in Ca 2+ -free digestion solution (in mM: 80 Naglutamate, 55 NaCl, 6 KCl, 10 HEPES, 11 glucose, and 2 MgCl 2 ). First, DSM pieces were treated for 25-45 min at 37°C with 1-2 mg/ml papain, 1 mg/ml dithioerythreitol and 1 mg/ml bovine serum albumin in dissociation solution (in mM: 80 monosodium glutamate, 55 NaCl, 6 KCl, 2 MgCl 2 , 10 HEPES, and 10 glucose, adjusted to pH 7.3 with NaOH) and then DSM pieces transferred to digestion solution containing 1-5 mg/ml collagenase XI (Sigma) or collagenase type 2, 1 mg/ml bovine serum albumin, 0 or 1 mg/ml trypsin inhibitor and 100 μM Ca 2+ , for 6-30 min. Following incubation, the digested tissue was washed several times in digestion solution without enzymes and Ca 2+ and then gently triturated to yield single smooth muscle cells. 
Discussion
The procedures described here explain the steps involved in the preparation of viable, freshly isolated DSM cells from whole thickness human urinary bladder specimens using enzymatic digestion and in the recording of whole-cell cation currents sensitive to the TRPM4 channel inhibitor 9-phenanthrol employing the amphotericin-B perforated patch-clamp approach. The enzymatic procedure relies on a two-step sequential exposure referred to herein as the sequential papain-collagenase digestion method. DSM tissues are first treated with papain and dithiothreitol (an enzyme stabilizing agent) under a nominal Ca 2+ -free condition, followed in the second step by collagenase type II in the presence of low Ca 2+ . The rationale for carrying out papain digestion under low Ca 2+ conditions in smooth muscle cells dates back to the late 1980's. Freshly isolated carotid artery smooth muscle cells prepared with papain displayed an elongated shape, showed viability (resistance to Trypan Blue uptake) and responded to contractile stimuli (higher Ca 2+ and histamine) 65 . Years later, this method was applied in the preparation of DSM cells (see Table 1 ). The choice of collagenase type II rather than other types relates to its relatively high proteolytic activity ideally suited for smooth muscle tissues including DSM. Indeed, collagenase treatment alone could yield single DSM cells albeit requiring extensive enzyme exposure (≥60 min) 53, 54 . Since collagenase activity depends on Ca 2+ and the enzyme is inactive under the Ca 2+ -free conditions, optimum enzymatic digestion of DSM pieces requires the presence of Ca Table 2) . After enzymatic treatment, digested DSM pieces are washed gently a number of times with cold DS without enzymes or Ca 2+ to remove any enzyme bound to tissues. The ice-cold DS helps to preserve DSM cell integrity and to limit enzymatic activity of any remaining papain or collagenase. In the last step, trituration of enzyme-treated DSM pieces with a fire polished Pasteur pipette releases single DSM cell. DSM cells are either immediately placed onto a recording chamber for patch-clamp studies or other types of experimentation or stored on ice in DS for use later on the same day (typically within 8 hrs of preparation, but the cells remain viable for up to 24 h).
We identified several important considerations for successfully obtaining single DSM cells. The first pertains to the human DSM specimen source quality. To optimally preserve tissue integrity, DSM samples obtained from open bladder surgeries are placed in ice-cold DS as soon as possible and maintained in a cold environment. Specifically, upon surgical extraction from the patient, the bladder specimen is immediately placed on a fully prepared side table in the operating room. Gross examination of the whole specimen (usually obtained during radical or simple cystectomy) and its opening follow. After visual inspection, a piece of whole thickness urinary ladder specimen is removed from a remote area of the specimen grossly uninvolved with tumor and immediately placed into a cup (either 50 or 100 mL) containing cold (~4 °C) Dissection Solution (DS) ( Table 2 ) and then tightly closed with a lid. Due to the planned nature of the harvesting of the tissue, the operating room personnel and auxiliary staff doing the harvesting are alerted at the start of the surgical case in order to have the materials available in the operating room at the time of tissue extraction. These precautions along with the routine, repetitive nature of the processing steps keep the warm ischemia time for the tissue -from extraction to placement in the chilled container with DS solution -to less than 5 min. The container is then placed in a refrigerator or on ice in a cooler to maintain the cold environment and transported (ice-cold) to the laboratory. Once the specimen arrives in the laboratory, dissection and enzymatic dissociation steps commence. It is very difficult to predict whether a given DSM specimen will yield high quality DSM cells following enzymatic dissociation, so we proceed with the enzymatic dissociation steps. In many cases, in parallel with electrophysiological experiments, our group conducts isometric tension recordings on DSM strips prepared from the same DSM specimens. We have found that we can usually obtain high quality DSM cells from preparations that also successfully provide viable strips for isometric contraction studies (our unpublished observation).
The second factor relates to different enzyme lot variabilities. We observed that for both papain and collagenase type II, each time a new lot of enzyme arrives from a supplier, the enzyme activity in DS for tissue digestion can vary. We, hence, routinely optimize the enzyme concentration and incubation intervals for each new lot. To minimize the lot variability contribution, we order larger quantities of the same lot and make a large batch of stock solutions in 2 mL aliquots of enzymes and store them at ~-20 °C until use. Over time, however, frozen stocks (stored up to 2 weeks) can lose their enzymatic activity. The third variable relates to the temperature of enzyme digestion treatments. Enzymatic activities of both papain and collagenase display temperature-dependency. Papain and collagenase type II exhibit activity in the temperature ranges encompassing normal body physiology 67, 68 also impair protein structures of ion channels, receptors, and transporters, adversely affecting their functionality. Interpretation of results obtained from enzymatically obtained, freshly isolated cells should bear this consideration in mind. Optimization of enzyme digestion conditions aims to increase the percentage of highly viable cells. Experimental approaches relying on a higher number of viable cells such as microarray analyses require more robust optimizations than those successfully carried out on fewer cells such as single-cell patch-clamp electrophysiology or Ca 2+ imaging. Consideration of the aforementioned factors has guided our research efforts over the last decade in obtaining high quality single DSM cells.
The perforated patch-clamp technique has been a mainstay electrophysiological approach for over a quarter of a century. Several publications provide details of the technical considerations 69, 70, 71, 72, 73 . Cell perforation can be obtained with amphotericin-B, nystatin, gramicidin, or βescin (see reference 32 for overview of each). The main advantage of perforated patch-clamp recordings over other electrophysiological approaches is that the native intracellular environment -including intracellular Ca 2+ and signaling molecules (e.g., cAMP, PKA, phosphates, and phosphodiesterases) -is preserved. This technique is, hence, ideally suited for investigating whole-cell ion channel currents and their regulatory mechanisms under near physiological conditions. A key caveat is that intracellular cell composition cannot be precisely controlled unlike other electrophysiological methods such as conventional whole-cell and single-channel excised-patch (inside-and outside-out) recordings. In our experience, three factors routinely contribute to successful , and non-selective cation currents from human, guinea pig, mouse, and/or rat DSM cells 17, 21, 22, 23, 29, 30, 31, 35, 60 . Here, we describe conditions for recording non-selective cation currents in human DSM cells. 9-Phenanthrol, a blocker of TRPM4 channels, attenuated voltage-step induced currents supporting the role of these channels in the control of DSM excitability. As a note, it usually requires at least 45 min after obtaining a giga-seal and initiation of perforation to record optimum stable voltage-step induced non-selective cation currents. Voltage ramps can also be used as an alternative to voltage-step protocols 30, 64 . Here, a voltage-step protocol from a hyperpolarized holding membrane potential was preferred rather than a ramp protocol since the former approach minimizes the effect of voltage-dependent inactivation and allows for averaging of evoked current over a duration of a voltage-step where the ramp provides a single data point per voltage. The latter point especially applies to human DSM cells as the currents show variable activity during voltage steps (Figure 5 and Figure 6) . The amphotericin-B perforated patch-clamp technique has been essential in identifying the properties of DSM cells and other cell types and will continue to aide in providing novel discoveries in the future. Furthermore, freshly isolated single DSM cells can be successfully used for measuring whole-cell K + , Cl -, and Ca 2+ currents with the conventional mode of the patch-clamp technique, membrane potential recording with the current clamp, and single channel recordings as exemplified by our prior reports 23, 29, 35, 64 .
In addition to single cell patch-clamp methods, freshly isolated DSM cells can be studied with other technical approaches including Ca 2+ imaging, RT-PCR/q-RT-PCR, immunocytochemistry, in situ proximity ligation assay, and genomic approaches (e.g., microarray, RNA-seq, CHIPseq) 15, 18, 30, 33, 34 . As single cell transcriptome determination methods continue to evolve and become highly sensitive, we envision in a future ability to routinely and specifically link electrical or pharmacological properties of individual DSM cells with their transcriptome/proteome profiles. This will be achieved by first recording from a DSM cell and then extracting mRNA or protein followed by transcriptomic/proteomic analyses. Although such methods have been tested already in non-DSM cells, they are at present technically challenging, lack sensitivity to be considered routine, and limited to successful detection of a few selected gene products 74 . Function-molecular profile expression linking studies when done on DSM cells obtained from urinary bladders derived from control and diseased patient-donors will provide insights into physiological processes essential for driving normal DSM functions, pathogenesis, and in identifying effective novel therapeutic approaches.
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